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Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease, affecting almost 1% of 
the world population. Although the cause of RA remains unknown, the complex interaction between 
immune mediators (cytokines and effector cells) is responsible for the joint damage that begins at the 
synovial membrane. Activated macrophages are critical in the pathogenesis of RA and showed 
specifically express a receptor for the vitamin folic acid (FA), folate receptor β (FRβ). This particular 
receptor allows internalization of FA-coupled cargo.  
In this work we will address the potential of nanoparticles as an effective drug delivery system for 
therapies that will directly target activated macrophages. Special attention will be given to stealth degree 
of the nanoparticles as a strategy to avoid clearance by macrophages of the mononuclear phagocytic 
system (MPS).  
This work summarizes the application of FA-target nanoparticles as drug delivery systems for RA and 
proposes prospective future directions [1]. 
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